BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...

Eli Lilly (LLY) reported first quarter earnings on Thursday, beating Wall Street's expectations on the top and bottom lines, but its stock sank more than 11% in trading despite the win.

Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly (NYSE ... Demand has been through the roof, and they generated a combined $16.5 ...

The ACHIEVE-1 results of orforglipron in type 2 diabetes patients further improve Eli Lilly’s leadership position in this market and these results also offer a good read-through to other trials.

HSBC cut its rating to "reduce" from "buy," and slashed its price objective Eli Lilly And Co (NYSE:LLY) stock is 1.6% lower to trade at $870.31 at last check, after a rare double downgrade from ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions.

Here’s what to know about Eli Lilly’s pill, which still must go through a review process by the Food and Drug Administration to be approved for sale. Eli Lilly said that it planned to seek ...

according to which Wall Street analysts expect both companies to continue raising their dividend payments through 2027, but the Danish giant will do so at a faster rate [20% versus Eli Lilly's 12% ...

PLEASANT PRAIRIE, Wis. — Eli Lilly and Company won final approval for site and operation plans for additions to its Pleasant Prairie facility. In December, the company announced an expansion in ...

Eli Lilly (LLY) closed the latest trading day at $822.27, indicating a -0.22% change from the previous session's end. This change lagged the S&P 500's daily gain of 0.49%. Elsewhere, the Dow lost ...